KayoThera lands $8m Series A
KayoThera Inc, an early-stage therapeutics company developing novel cancer immunotherapies, has secured $8 million in Series A financing.
KayoThera Inc, an early-stage therapeutics company developing novel cancer immunotherapies, has secured $8 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination